PharmiWeb.com - Global Pharma News & Resources

Press Releases - 2020-11-09

Date Title Company
09-Nov-2020 Sarcoma Treatment Market 2020 Global Size, Share, Growth Opportunities, Comprehensive Analysis, Competitive Landscape, Future Prospects with Regional Trends by Forecast 2027 CDN Newswire
09-Nov-2020 Thyroid Eye Disease Treatment Market 2020 Global Industry Growth Analysis, Segmentation, Size, Share, Trend, Future Demand and Leading Players : Horizon Therapeutics, Bausch & Lomb Incorporated, Pfizer, Janssen Biotech, Kala Pharmaceuticals, Hi-Tech Pharmacal Co., by 2026 CDN Newswire
09-Nov-2020 Optic Nerve Disorders Treatment Market Size, share, Analysis By 2027 | Global Industry Growth Rate, Technology Trends, Competitive Landscape, Demand Overview, Key Region CDN Newswire
09-Nov-2020 Enalare Therapeutics Appoints Daniel Motto as Chief Business Officer Newswire
09-Nov-2020 I-Mab Reports Phase 1 Clinical Trial Data of Highly Differentiated Anti-CD47 Monoclonal Antibody Lemzoparlimab at the 2020 SITC Annual Meeting I-Mab
09-Nov-2020 Berkshire Biomedical to Participate in 5th Annual Investival Showcase Virtual Berkshire Biomedical, LLC
09-Nov-2020 CARMA Cell Therapies(TM) to Share Results of In-vitro Characterization of MCY-M11 at SITC 2020 Annual Meeting MaxCyte, Inc.
09-Nov-2020 Alkermes Presents New Data on ALKS 4230 at Society for Immunotherapy of Cancer's (SITC) 35th Anniversary Annual Meeting Alkermes plc
09-Nov-2020 Alkermes Presents New Data on ALKS 4230 at Society for Immunotherapy of Cancer's (SITC) 35th Anniversary Annual Meeting Alkermes plc
09-Nov-2020 CNS Pharmaceuticals Announces Adaptive Trial Design For Berubicin Phase 2 Clinical Trial To Be Submitted for FDA Review CNS Pharmaceuticals, Inc.
09-Nov-2020 Prometheus Biosciences Announces $130 Million Financing to Advance Precision Medicines for the Treatment of Inflammatory Bowel Disease Prometheus Biosciences, Inc.
09-Nov-2020 Merck Announces Out-Licensing Agreement for Investigational Atacicept with Vera Therapeutics Merck
09-Nov-2020 FDA Grants Rare Pediatric Disease Designation to AMO Pharma for AMO-02 for Treatment of Congenital Myotonic Dystrophy AMO Pharma Limited
09-Nov-2020 Pliant Therapeutics to Present Data at The Liver Meeting® 2020 Pliant Therapeutics, Inc.
09-Nov-2020 New XARELTO® (rivaroxaban) Peripheral Artery Disease (PAD) Data from EXPLORER Clinical Research Program to be Unveiled at American Heart Association (AHA) Scientific Sessions 2020 Janssen Pharmaceutical Companies of Johnson & Johnson
09-Nov-2020 Nektar Therapeutics to Host Webcast Conference Call for Analysts & Investors with Expert Oncologist Panel During 2020 Society for Immunotherapy of Cancer (SITC) 35th Annual Meeting Nektar Therapeutics
09-Nov-2020 Phio Announces Positive In Vivo Data On Combination PD-1 And TIGIT Checkpoint Blockade With INTASYL In A Single Therapeutic For Cancer Treatment Phio Pharmaceuticals Corp.
09-Nov-2020 OncoHost to Present Data on Predicting Host Response to Immunotherapy in Melanoma Patients at SITC 2020 OncoHost
09-Nov-2020 MEI Pharma to Present at Two Upcoming Investor Healthcare Conferences MEI Pharma, Inc.
09-Nov-2020 Amgen Presents First Clinical Data for AMG 757 at SITC 2020 Amgen